Peter DeMuth - Chief Scientific Officer at Elicio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Issuer Symbol
ELTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Peter DeMuth since 11 Mar 2025

Holdings reported by Peter DeMuth for Elicio Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 21,543 $171,482 $7.96 02 Feb 2026 Direct
Stock Option (Right to Buy) 41,600 02 Feb 2026 Direct Common Stock

Transactions reported by Peter DeMuth for Elicio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.